Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644953 · ClinicalTrials.gov registry record · Phase 2
Hydroxyurea and Transfusion
A Phase 2 study, sponsored by Children's National Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT03644953 is a Phase 2 study that has completed, run by Children's National Research Institute. The registered enrollment target is 14 participants.
The verdict
NCT03644953, a Phase 2 study, has completed, sponsored by Children's National Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will prospectively investigate the feasibility, safety, and transfusion requirements of adding hydroxyurea to simple chronic transfusions for patients with sickle cell anemia already on chronic transfusions.
Interventions
- DRUG Hydroxyurea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2021-07-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03644953
The ClinicalTrials.gov registry entry for NCT03644953 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydroxyurea is the first listed.
NCT03644953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03644953 about?
NCT03644953 is a clinical study titled "Hydroxyurea and Transfusion". This study will prospectively investigate the feasibility, safety, and transfusion requirements of adding hydroxyurea to simple chronic transfusions for patients with sickle cell anemia already on chronic transfusions.
What is the current status of trial NCT03644953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2018-10-30. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03644953?
The interventions under investigation include: Hydroxyurea (DRUG).
Who is sponsoring clinical trial NCT03644953?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.